In agreement with our hypothesis that ANGPTL4 contributes to bone erosions in RA, ‘high ANGPTL4’ patients were significantly more likely to have detectable concentrations of serum RANKL. The gene discussed is TNFSF11; the disease is rheumatoid arthritis.